Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome

Clinical trial NCT06518005 · RECRUITING

Trial details

NCT number: NCT06518005
Sponsor: Genethon
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crigler-Najjar Syndrome

Start date: 2024-11-08
Primary completion: 2026-09-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.